Actualización en el uso del PET/CT en sarcoma de Ewing, a propósito de un caso
| Autor: | Daniela Barahona Z, María Ignacia Faure R., Isabel Adlerstein L. |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Fluorodeoxyglucose
Treatment response medicine.diagnostic_test business.industry Cancer Sarcoma Ewing General Medicine medicine.disease Scintigraphy medicine.anatomical_structure Bone Marrow Fluorodeoxyglucose F18 Positron emission tomography Positron Emission Tomography Computed Tomography Biopsy medicine Sarcoma Bone marrow Radionuclide Imaging business Nuclear medicine medicine.drug |
| Zdroj: | Revista médica de Chile v.148 n.10 2020 SciELO Chile CONICYT Chile instacron:CONICYT |
| ISSN: | 0034-9887 |
| DOI: | 10.4067/s0034-98872020001001504 |
| Popis: | The use of positron emission tomography with computed tomography (PET/CT) for adult cancer patients is widespread, however, its use in pediatric patients is limited by fear of radiation, monetary cost and lack of awareness of its greater sensitivity in the evaluation of some types of tumors. Ewing's sarcoma is one of the primary pediatric malignancies in which PET/CT with 18F-labeled fluorodeoxyglucose (18F-FDG) has demonstrated greater sensitivity in the evaluation of bone metastases compared to scintigraphy, as well as in the evaluation of treatment response. We report a 13 years old female consulting for retrosternal pain. A chest CT scan showed an infiltrating mass originating in the sternum. A biopsy confirmed the presence of an Ewing sarcoma. The tumor was staged with PET/CT which showed multiple bone lesions not visible in previous studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|